1. Home
  2. ACB vs NAGE Comparison

ACB vs NAGE Comparison

Compare ACB & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Cannabis Inc.

ACB

Aurora Cannabis Inc.

N/A

Current Price

$4.07

Market Cap

232.3M

Sector

Health Care

ML Signal

N/A

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

N/A

Current Price

$2.35

Market Cap

212.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACB
NAGE
Founded
2013
1999
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.3M
212.8M
IPO Year
2016
2010

Fundamental Metrics

Financial Performance
Metric
ACB
NAGE
Price
$4.07
$2.35
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$4.29
★ $12.08
AVG Volume (30 Days)
★ 986.4K
535.9K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 81.82
EPS
N/A
★ 0.09
Revenue
N/A
★ $129,423,000.00
Revenue This Year
N/A
$2.91
Revenue Next Year
$9.38
$16.17
P/E Ratio
★ N/A
$27.83
Revenue Growth
N/A
★ 29.95
52 Week Low
$2.56
$2.39
52 Week High
$6.36
$7.95

Technical Indicators

Market Signals
Indicator
ACB
NAGE
Relative Strength Index (RSI) 49.87 30.80
Support Level $3.75 N/A
Resistance Level $4.15 $3.61
Average True Range (ATR) 0.14 0.09
MACD -0.02 0.01
Stochastic Oscillator 43.00 8.06

Price Performance

Historical Comparison
ACB
NAGE

About ACB Aurora Cannabis Inc.

Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: